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Abstract 
Haemodialysis (HD) patients are at risk of sarcopenia. Newer bioimpedance 
devices (BIS) using a 3 compartmental body composition model, separate 
extracellular water (ECW) over–hydration from normo-hydrated lean tissue 
mass (LTM) and adipose tissue mass (ATM). During HD hydration status 
changes, along with changes in electrolytes and solutes, and may alter body 
composition measurements. As such we measured BIS and serum osmotic 
pressure (sOP) pre and post-dialysis in 43 patients. There were no significant 
changes in LTM (39.5±15.1 vs 39.3±15.2 kg) or sOP (33.2±8.3 vs 35.9±9.7 mmHg). 
Higher post-dialysis sOP was associated with a greater percentage fall in LTM 
(r=0.43, p=0.08) and increase in ATM (r=-0.43, p=0.017). Increased sOP post-
dialysis was associated with a reduction in LTM (r=0.36, p=0.033) and increased 
ATM (r=-0.44, p=0.013). Changes in sOP with HD are associated with changes in 
BIS body composition measurements. BIS measurements should preferably be 
made when patients are least over-hydrated. 
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 Haemodialysis patients are at increased risk for sarcopenia, which is 
associated with increased mortality [1]. The European Society for Parenteral 
and Enteral Nutrition guidelines recommend dual X ray absorptiometry (DXA) 
and bioimpedance assessments to detect muscle wasting [2]. Bioimpedance is 
more convenient than DXA, and reports have shown equivalence in determining 
body composition [3]. Both methods typically divide the body into a two 
compartmental model of fat and fat free mass. However, assessments can be 
affected by hydration status [4]. Haemodialysis patients are volume overloaded 
pre-dialysis and fluid is removed during the dialysis session. Thus, post-dialysis 
measurements would potentially be more reliable when assessing muscle mass, 
but requires patients to remain behind after the dialysis session. More recently 
a three compartmental bioimpedance spectroscopy (BIS) model has been 
developed, separating extracellular water (ECW) over hydration from normally 
hydrated lean tissue mass (LTM) and normally hydrated adipose mass (ATM) [5]. 
Potentially this model would allow bioimpedance measurements of body 
composition to be made more conveniently pre-dialysis, as LTM and ATM should 
not change with removal of ECW excess. During haemodialysis, along with the 
change in ECW, there is also a change in electrolytes and serum osmolality, and 
as the bioimpedance model is based on the concept of measurement at a normo-
hydrated state we investigated whether body composition changes with dialysis 
[6] were associated with the changes in osmolality, as haemodialysis patients will 
differ not only in terms of hydration status but also electrolyte balance and 
uraemic solutes. 
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 As part of clinical service development (UK NHS guidelines for clinical 
audit and service development (http://www.hra.nhs.uk/documents /2013/09/ 
defining-research.pdf), we measured serum osmotic pressure (sOP) in 43 
haemodialysis patients, using a colloid osmometer ( Osmomat 050, Genotec, San 
Francisco, USA) and compared changes with pre and post-dialysis BIS (Body 
Composition Monitor, Fresenius AG, Bad Homburg, Germany), measured in a 
standardised manner, with electrodes placed in accordance with manufacturer’s 
instructions contra-laterally to fistulae, and post measurements delayed to allow 
for equilibration [6,7].  Patient characteristics: 30 male (69.8%), mean age 
64.5±17.8 years, median dialysis session  was 3.5 (3.0-4.0) hours, dialysate 
temperature 35.0 (35.0-35.4)0C, sodium 138 (137-140) mmol/L potassium 2.0 (1-
2) mmol/L, and  ultrafiltration rate 8.1 ±4.3 ml/kg/h.  Weight and serum urea 
fell post-dialysis, and there were no statistically significant overall changes in 
body composition (table 1). Calculated serum osmolality, using serum urea, 
sodium, potassium and glucose, fell from 314 ±15.1 to 303.9±10.0 mOsmol/kg, but 
no significant change in measured sOP (table 1). There was a correlation between 
measured pre-dialysis sOP and calculated osmolality (r=0.37, p=0.04), and serum 
urea (r=0.53, p=0.001), but not between post-dialysis measurements. There was 
no correlation between pre-dialysis measured sOP and body composition or ECW 
status. The post-dialysis measured sOP correlated with the percentage fall in 
total body water (TBW), intra-cellular water (ICW), LTM, and negatively with 
ATM (table 2). However, there was no correlation with the change in patient 
weight, or ultrafiltration rate. 
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 We then compared the change in sOP and changes in body composition. An 
increase in sOP post-dialysis was associated with a fall in body cell mass (BCM), 
and LTM and negatively with ATM (Table 2). 
 
 Although overall the mean body composition values in terms of LTM, ATM  
, and BCM measured with BIS did not significantly change post-dialysis, at the 
individual patient level there were changes in body composition.  Total body 
weight and serum urea fell post-dialysis. Although there was a correlation 
between sOP and both serum urea concentration and calculated serum osmolality 
pre-dialysis, there was no such correlation post-dialysis. Standard equations for 
calculating serum osmolality are based on serum sodium, potassium, glucose and 
urea concentrations. Whereas measured sOP pre-dialysis would also include the 
other uraemic osmolytes and proteins, and then post dialysis the competing 
effects of osmolyte clearances, changes in electrolytes and the effect of 
plasma water volume contraction. Depending upon the balance between the fall in 
osmolytes and plasma water contraction, sOP post-dialysis increased in some 
patients and fell in others.  
We found that the greater the post-dialysis sOP, then the greater the 
percentage fall in ICW and TBW and also LTM, whereas ATM increased. There 
was no correlation between post-dialysis sOP and either relative weight change 
or ultrafiltration rate. 
Similarly, an increase in sOP post-dialysis was associated with a reduction 
in LTM and BCM, and an increase in ATM . Conversely when sOP decreased post 
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dialysis, then LTM and BCM increased, and ATM fell.  Previous bioimpedance 
studies have variously reported a fall in fat free mass and increase in fat mass, 
or an increase in ICW and BCM [8]. Over estimation of fat free mass has been 
ascribed to increased ECW pre-dialysis, as muscle contains more water than fat. 
In theory, as the 3 compartmental model separates ECW excess from normally 
hydrated LTM and ATM, then there should be no changes in LTM or ATM 
following haemodialysis. However, the model is based on the concept of normally 
hydrated tissue, and tissue hydration will vary between haemodialysis patients 
due to hydration status, but also electrolyte balance and retention of uraemic 
solutes.  During dialysis not only are there changes in hydration status but also 
electrolyte fluxes and removal of uraemic solutes, leading to differences in 
estimation of ECW and ICW during dialysis [8,9]. As such this will lead to 
changes in intra-cellular osmolality and cell hydration, which will vary between 
patients, leading to differences in tissue hydration status compared to the 
bioimpedance estimated normo-hydrated state [10]. However, as with any 
measuring device, there are error ranges for impedance predictions and some of 
the observed pre-post differences may be within these limits, although the 
changes we have demonstrated linked to osmolality would suggest an effect on 
BIS measurements. 
We have demonstrated that using a 3 compartmental model estimates of 
lean and adipose tissue mass change post-dialysis, and that this is related in part 
to changes in osmotic pressure. Post-dialysis, patients are less over-hydrated, 
with a more normal electrolyte balance. Thus, for more reliable screening for 
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sarcopenia and measurements of lean tissue mass, then bioimpedance 
measurements should preferably be made post-dialysis. 
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Table 1. Pre and post-haemodialysis session body composition as measured with 
bioimpedance spectroscopy, and serum chemistries. Results expressed as mean 
±SD, or median (inter-quartile range). * p<0.05, ***<0.001 vs Pre-dialysis by 
appropriate paired testing. 
 
variable Pre-dialysis Post-Dialysis 
Weight kg 70.2 ±17.3 68.6 ±17.1 *** 
Lean Tissue mass kg 39.5 ±15.1 39.3 ±15.2 
Adipose Tissue mass kg 28.9 ±15.9 29.4 ±13.4 
Fat tissue kg 25.4 ±17.1 22.5 ±11.2 
Body Cell Mass Kg 21.9 ±10.2 20.8 ±10.3 
Serum urea mmol/L 21.4 ±10.8 7.6 ±4.9 
Serum sodium mmol/L 137.2 ±5.1 138.4 ±2.3 
Serum potassium mmol/L 5.3 ±0.8 3.7 ±0.5 *** 
Serum glucose mmol/L 7.7 ±2.5 7.2 ±1.6 
Serum Albumin g/L 31.3 ±5.9 32.6 ±5.2 * 
Osmotic pressure mmHg 33.2 ±8.5  35.9 ±9.7 
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Table 2. Spearman univariate correlation between post dialysis measured serum 
osmotic pressure and percentage change in body composition (Pre-post dialysis 
variable/pre dialysis) and change in measured serum osmotic pressure and 
change in body composition (Pre –Post). Median (interquartile range). 
 
variables r p 
Post serum osmotic pressure   
% change total body water  0.9 (-6.4 to 10.1)  0.33 0.036 
% change intracellular water  -1.8 (-12.6 to 8.3) 0.34 0.030 
% change lean tissue mass  -1.3 (-16.7 to 13.2) 0.43 0.008 
%  change adipose tissue mass  26.5 (-16.7 to 37.6) -0.43  0.017 
Change measured osmotic pressure -4.3 (-9.6 to 5.6) mmHg   
Change  body cell mass -0.8 (-4.8 to 2.9) kg -0.38 0.025 
Change  lean tissue mass -1.0 (-6.7 to 4.4) kg -0.36 0.033 
Change adipose tissue 2.1 (-3.8 to 5.9) kg 0.44 0.013 
 
